Literature DB >> 27336073

A Rare Cause of Acute Abdominal Pain: Splenic Infarct (Case Series).

Engin Ozakin1, Osman Cetinkaya1, Filiz Baloglu Kaya1, Nurdan Acar1, Arif Alper Cevik1.   

Abstract

Splenic infarcts are rare cases. It may not be noticed in the emergency department because the clinical picture is likely to mimic various acute abdominal pains. The splenic infarct is often the result of systemic thromboembolism associated with cardiovascular disorders. The aim of this study is to present an evaluation of the patients that presented to the emergency department (ED) with abdominal pain and were diagnosed with splenic infarct.

Entities:  

Keywords:  D-dimer; Emergency department; infarct; spleen

Year:  2016        PMID: 27336073      PMCID: PMC4910014          DOI: 10.5505/1304.7361.2015.16769

Source DB:  PubMed          Journal:  Turk J Emerg Med        ISSN: 2452-2473


Introduction

Splenic infarction is a rare clinical condition. The presentation can mimic other causes of acute abdominal pain. The diagnosis is based on clinical presentation and imaging studies. It is mostly seen in conjunction with hematologic diseases, vascular and thromboembolic disorders. In this cases series we reported splenic infarcts presented with abdominal pain in emergency department.

Case Report

In this study, patients that presented to the adult ED (for patients over 18) of our hospital and were diagnosed with a splenic infarct between January 1, 2009 and January 1, 2013 were analyzed retrospectively. Age, gender, case history, triage category, complaints, pain characteristics, time when the pain started, vital and physical examination findings as well as the results of electrocardiogram (ECG), laboratory tests and radiological imaging were recorded. Three female and three male patients were included in this study. The average age of patients was 62.17±12.28 (range: 22–90). Table 1 provides the details of case history, examination, laboratory tests, imaging and clinical results.
Table 1

Demographic and clinical characteristics of patients

CharacteristicsCase 1Case 2Case 3Case 4Case 5Case 6
Age792690832273
SexMaleFemaleMaleFemaleMaleFemale
Triage category231131
SymptomsAbdominal pain, constipationAbdominal painAbdominal painAbdominal pain, nausea, vomiting and constipationAbdominal painAbdominal pain, nausea, vomiting and constipation
Onset of the pain4 hours3 days1 day30 days2 days5 days
Medicine/drugs/otherSmoke/alcoholSmoke, Coumadin
Tension arterial (mmHg)140/80110/80120/70110/7080/50110/60
Pulse (/min.)7980611017892
Respiratory rate (/min.)241828222619
Fever ('C)36.336.536.136.439.636.3
Past medical historyAsthma, HypertensionC/S operation (6 months ago), rubellaCOPD, DM, CHFAnaemia (AA)Aorta valve replacementCHD, HT
EKGAtrial fibrillationNSRNSRNSRNSRNSR, LVH
Abdomen examinationEpigastric tenderness rebound and defenceLeft upper quadrant tendernessDiffuse tendernessDiffuse tendernessDiffuse tendernessEpigastric tenderness and defence
Leukocytes (/mm3)22.0003800128001968056006400
D-dimer (μg/dl)20477780
Amylase (U/L)1093161649131
CT findingsInfarct in upper and middle poleSplenomegaly, infarct in lower and middle poleInfarct in middle poleMultiple infarcts in parenchymaInfarct in middle inferior poleInfarct in middle upper pole
Admission time (day)84125137
ConclusionDischargedDischargedDischargedDischargedDischargedDischarged
All patients had abdominal pain when they first presented to the ED. Abdominal pain was accompanied by nausea and vomiting in four patients, and by constipation in three patients. The pain started on average 7±4.64 (range: 1–30) days before the patients presented to the hospital. The evaluation of vital findings showed that four patients had tachypnea and one patient had a high fever. The medical history of patients included chronic obstructive pulmonary disease, congestive heart failure, mitral valve replacement, diabetes mellitus, asthma and brucella. According to the ECG results, one patient had atrial fibrillation. The abdominal examination showed three patients had sensitivity throughout, two patients had epigastric sensitivity and one patient had sensitivity in the left upper quadrant while two patients had rebound tenderness and guarding. The laboratory test results of three patients revealed high leucocyte values. The D-dimer test was performed on two patients, which revealed high values (see Table 1). The bedside ultrasound imaging did not indicate any pathological results apart from a hypoechoic lesion in spleen in one patient. All patients underwent an abdominal computerized tomography (CT) scan in the ED, the results of which were evaluated in the same unit. As a result of the CT scan, the radiology specialists reported a significant number of hypodense lesions that were likely associated with an infarct, and these findings were considered to confirm the presence of a splenic infarct (Figure 1a, b). All patients diagnosed with a splenic infarct were hospitalized. The average period of stay in the hospital was 8.16±1.49 (range: 4–13) days. The patients were discharged after conservative treatment, since none of them developed severe complications or mortality.
Figure 1

(a, b) Splenic infarction.

Discussion

Splenic infarction occurs as a result of tissue necrosis that develops due to parenchymal ischemia, which is a result of the interruption of arterial blood supply to the spleen. The infarct may occur in a segment of the spleen or in the complete spleen. Infiltrative hematologic disorders that cause the congestion of splenic circulation with abnormal cells or thromboembolism constitute the most common (88%) causes of an infarct. It was reported that the rate of splenic infarction development ranges from 50 to 72% in CML and myelofibrosis patients. Splenic infarction may also develop secondary to cardiovascular disorders, autoimmune/collagen tissue diseases, trauma, surgery (pancreatectomy or liver transplantation) or an infection. In 16.6% of patients, it is the first symptom of an underlying disease. In the present study, four patients had a risk factor for thromboembolism (patients taking warfarin due to coronary artery disease, congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, hypertension and valve replacement). No hematological diseases were detected according to medical history or clinical follow-up of any patients. As reported in the literature as a rare occurrence, one patient had a active brucella infection. In patients with a splenic infarct, the clinical presentation may be in the form of non-specific abdominal pain or hemorrhagic shock resulting from massive subscapular bleeding. In some cases, the clinical picture does not provide any indications, and the diagnosis is based on imaging, laparoscopy or laparotomy. The overall symptom is abdominal pain or abdominal pain in the left upper quadrant in two thirds of the patients.2, 4 Nausea and vomiting are also among early symptoms. Abdominal pain can be accompanied by fever, shivering, pleuritic chest pain and left shoulder pain (Kehr finding). Pain often has been occurring for at least one week in half of patients. The most common symptom found on physical examination was left upper quadrant pain. All patients presenting to our clinics had abdominal pain and sensitivity in abdomen. In five patients, the pain lasted for less than one week. There is no disease-specific laboratory test used for diagnosis. The leucocyte count may be over 12000/m3 in 50% of patients, and 7% of patients may have thrombocytosis.4, 5 In concordance with the literature, the leucocyte values of three patients in our study were high. The D-dimer test was performed for two patients with the pre-diagnosis of mesenteric embolism, and the value was high for both patients. Given that there are a limited number of studies related to the link between D-dimer and splenic infarct in the literature, D-dimer values of cases seems to be high.2, 6 This result leads us to think that because etiology is generally secondary to thromboembolism, D-dimer, a fibrin degradation product found in clotting disorders, may be useful for excluding splenic infarction. However, there is a need for further research. The other laboratory test results did not present any pathological findings. CT scan with contrast is the best method and option for the diagnosis of splenic infarct. It is also more advantageous than other diagnostic methods for the identification of other pathologies. The possibility of splenic infarct should be considered in patients at risk and with non-specified left upper quadrant pain, and a CT scan should be performed. Magnetic resonance imaging by intravenously injected gadolinium contrast medium is another option. Research on splenic infarcts indicates that ultrasound imaging is a method that may be preferred. Ultrasound is useful if the spleen parenchyma can be identified. In the acute phase of infarction, the incidence of negative imaging is high in B-mod ultrasound scan, and another research puts that its diagnostic value is 18%. In cases where the infarction area is large, color Doppler ultrasound may show the area without blood. Recent studies suggest that in patients with suspected splenic infarct, the incidence of imaging the infarct increases up to 100% with the use of second-generation ultrasound contrast agents.10, 11 In the present case, an abdominal CT scan was used for imaging since the patientspain did not alleviate during the follow-up period; the left upper quadrant pain continued on physical examination and the laboratory findings did not provide any pathologies that explained the clinical situation. Before the CT, the patients underwent bedside ultrasound scan, which showed one patient had a hypoechoic lesion with an irregular contour. The results for the other patients did not present any pathological findings or abdominal free fluid. The fact that all patients were discharged from the hospital after conservative treatment may indicate that the clinical situation and lesions were in a mild form. This may explain why the ultrasound imaging failed to show the lesions in other five patients. The diagnosis of splenic infarct has increased because of using abdominal radiological imaging techniques more frequently and opting for angiographic embolization more commonly in vascular injuries of the spleen. The present guidance approaches suggest conservative follow-ups in cases of uncomplicated and asymptomatic splenic infarcts. Nevertheless, surgery is preferred in case of complications such as resistant symptoms, bleeding, rupture, abscess and pseudocyst.

Conclusion

Splenic infarction, a cause of abdominal pain, is rarely encountered and often unnoticed. The diagnosis is based on clinical suspicion and imaging. Abdominal CT is the first option for diagnosis. Splenic infarction should certainly be considered in differential diagnosis of patients presenting to the emergency department due to abdominal pain, in view of underlying and risk-posing diseases. A D-dimer test may be used for excluding the diagnosis of splenic infarct; however, there is a need for further research.

Conflict of Interest

The authors declare that there is no potential conflicts of interest.
  11 in total

1.  Second-generation sonographic contrast agent for differential diagnosis of perisplenic lesions.

Authors:  Christian Görg; Tillmann Bert
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

Review 2.  Focal splenic lesions: US findings.

Authors:  M Caremani; U Occhini; A Caremani; D Tacconi; L Lapini; A Accorsi; C Mazzarelli
Journal:  J Ultrasound       Date:  2013-05-04

3.  Ultrasonography of splenic abnormalities.

Authors:  Ming-Jen Chen; Ming-Jer Huang; Wen-Hsiung Chang; Tsang-En Wang; Horng-Yuan Wang; Cheng-Hsin Chu; Shee-Chan Lin; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  Massive splenic infarction due to left ventricular apical thrombus in a patient with giant splenomegaly.

Authors:  Tomoya Hara; Koji Yamaguchi; Masataka Sata
Journal:  Heart Asia       Date:  2012-01-01

5.  Cholesterol embolism: experience with 22 histologically proven cases.

Authors:  P J Dahlberg; D F Frecentese; T H Cogbill
Journal:  Surgery       Date:  1989-06       Impact factor: 3.982

6.  The clinical spectrum of splenic infarction.

Authors:  M Nores; E H Phillips; L Morgenstern; J R Hiatt
Journal:  Am Surg       Date:  1998-02       Impact factor: 0.688

7.  The natural history of splenic infarction.

Authors:  M T Jaroch; T A Broughan; R E Hermann
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

8.  Splenic infarction: sonographic patterns, diagnosis, follow-up, and complications.

Authors:  C Goerg; W B Schwerk
Journal:  Radiology       Date:  1990-03       Impact factor: 11.105

9.  Splenic infarct as a diagnostic pitfall in radiology.

Authors:  Sanjeev C Joshi; Ishita Pant; Aditya N Shukla; M A Anshari
Journal:  J Cancer Res Ther       Date:  2008 Apr-Jun       Impact factor: 1.805

10.  Splenic infarction: 10 years of experience.

Authors:  Meir Antopolsky; Nurit Hiller; Shaden Salameh; Beth Goldshtein; Ruth Stalnikowicz
Journal:  Am J Emerg Med       Date:  2009-03       Impact factor: 2.469

View more
  5 in total

1.  Multiple splenic infarctions in a dog with immune-mediated hemolytic anemia: therapeutic implications.

Authors:  S M Kim; G N Kim; S W Jeong; J H Kim
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

2.  Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe.

Authors:  ELMustafa Abdalla; Muzamil Musa; Motwakil Musa; Ahmed Hatem; Abdalla Fadul; Ashraf Oe Ahmed
Journal:  Eur J Case Rep Intern Med       Date:  2022-06-29

3.  Left lower quadrant pain: an unlikely diagnosis in a case of acute abdomen.

Authors:  Jennifer Williams; Shumona Ima; Charles Milrod; Mahesh Krishnamurthy
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-10-15

4.  Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis.

Authors:  Alexander Anderson; Mary Seddon; Khalid Shahzad; Raimundas Lunevicius
Journal:  BMJ Case Rep       Date:  2021-12-07

5.  Complete splenic infarction in association with COVID-19.

Authors:  Graham Prentice; Stephen Wilson; Alexander Coupland; Stephen Bicknell
Journal:  BMJ Case Rep       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.